InfuSystem (NYSE:INFU) Stock Price Down 2% – Here’s What Happened

InfuSystem Holdings, Inc. (NYSE:INFUGet Free Report)’s stock price traded down 2% on Monday . The stock traded as low as $9.15 and last traded at $9.35. 166,555 shares traded hands during trading, an increase of 24% from the average session volume of 134,286 shares. The stock had previously closed at $9.54.

Wall Street Analysts Forecast Growth

Separately, Roth Mkm reissued a “buy” rating and issued a $15.00 price objective (up from $14.00) on shares of InfuSystem in a report on Tuesday, February 24th. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $15.00.

Check Out Our Latest Analysis on INFU

InfuSystem Stock Performance

The company has a market cap of $189.01 million, a P/E ratio of 155.86 and a beta of 1.66. The stock has a 50 day moving average price of $8.70 and a two-hundred day moving average price of $9.24. The company has a quick ratio of 1.59, a current ratio of 1.98 and a debt-to-equity ratio of 0.50.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in INFU. Hillsdale Investment Management Inc. bought a new stake in shares of InfuSystem in the third quarter valued at about $4,665,000. Teton Advisors LLC bought a new position in InfuSystem during the third quarter worth about $1,917,000. Minerva Advisors LLC increased its position in InfuSystem by 9.2% during the second quarter. Minerva Advisors LLC now owns 994,781 shares of the company’s stock worth $6,178,000 after acquiring an additional 84,104 shares during the period. Legato Capital Management LLC raised its stake in InfuSystem by 5.5% in the 3rd quarter. Legato Capital Management LLC now owns 86,745 shares of the company’s stock worth $899,000 after purchasing an additional 4,534 shares in the last quarter. Finally, Carrera Capital Advisors acquired a new stake in InfuSystem in the 4th quarter worth about $101,000. Institutional investors own 71.13% of the company’s stock.

About InfuSystem

(Get Free Report)

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.

See Also

Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.